Specific Guidance for Women Embarking on Pregnancy with Cardiovascular Diseases -Precautionary Measures for Avoidance of Complications by Utilization of Multidisciplinary Team Strategy -A Review

Having reviewed the different significant etiopathogenesis and role of different antiobesity agents, comprehensively, role of adipocytokines in Heart failure with preserved ejection fraction (HFpEF) HFpEF and HF with reduced(<40%) ejection fraction(HFrEF), role of SGLT2 Inhibitors beyond Glycosuria in controlling obesity, NAFLD Treatment, Pancreatic β Cell Protection Besides Therapy for Diabetes Mellitus, CVOT and Renoprotection including MACE withSGLT2 Inhibitors molecular modes Implicated in Diastolic Impairment in early HFpEF and HFrEF, and epigenetics modifications in diabetic cardiomyopathy(DbCM),with Role of SGLT2 Inhibitors and GLP-1RA in therapy of DbCM here we have concentrated on the plethora of persons with manifestation in the form of cardiovascular disease (CVD) possesses the capability of gaining advantages from the accessibility of assisted reproductive technologies (ARTs) regarding generating family building. Utilization of this for such population needs to be in lieu of underlying infertility, a requirement for fertility preservation conducted prior to disease inimicality or heart transplant, a genetic cardiac disorder they deemed to prevent passing to offspring, or the requirement of utilization of a gestational surrogate in the scenario of (CV) contraindications to pregnancy. CVD presentation is in the form of a spectrum, from mild as well as frequent diseases that possess least challenges to maternal health at the time of pregnancy to robust in addition to sparse diseases with a high risk of morbidity, along with maternal mortality if ART or pregnancy is embarked upon. In this review, here we detail the properties of variable CVD from the vision of the patient who is in the age with reproduction embarking on ART. Classification of the imperative steps in the preART assessment from the multidisciplinary team, detail risk stratification prior to ART treatment as well as plausible subsequent pregnancy, in addition toyieldparticular corroboration dependent recommendations on the care of such patients at the time of the in vitro fertilization and embryo transfer(IVF-ET) cycles.